Pulmonary Hypertension and Its Determinants in Beta-thalassemia Major and Intermedia Considering Left Ventricular Functional Stat
Authors
Abstract
Introduction: Pulmonary hypertension (PHT) is a common complication in Beta-thalassemia. We aimed to determine the prevalence of PHT and its main indicators in patients with Beta thalassemia Major (TM) and Beta-thalassemia Intermedia (TI), considering left ventricular function.
Methods: Pulmonary hypertension (PHT) is a common complication in Beta-thalassemia. We aimed to determine the prevalence of PHT and its main indicators in patients with Beta thalassemia Major (TM) and Beta-thalassemia Intermedia (TI), considering left ventricular function.
Results: The overall prevalence of PHT in TM and TI group was estimated to be 35.2% and 29.3%, respectively; while reduced LVEF was evident in 22.7% and 10.1% of patients with TM and TI, respectively. No significant correlation was observed between mean PAP and LVEF in the patients with TI (Pearson coefficient = -0.096, P value = 0.345); while, an adverse association was revealed between mean PAP and LVEF in patients with TM (Pearson coefficient = -0.227, P value = 0.033). Upon unte analysis, the only significant association was observed between LVEF and pulmonary hypertension among TM patients (P value = 0.001).Our results did not indicate that male gender and aging may affect the development of PHT.
Conclusions: According to our findings, a considerable proportion of patients with TM and TI may have PHT. We detected an adverse association between mean PAP and LVEF in patients with TM. Left ventricular function was reduced in patients with PHT among TM group.
Highlights
Copyright
© 2016, International Journal of Cardiovascular Practice. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
Malocclusion in subjects with beta-thalassemia major
Shahsavari F, Eslami M, FarahVash M. Malocclusion in subjects with beta-thalassemia major. koomesh. 2007;8(4):e152154. doi:
Prevalence of Alpha and Beta-Thalassemia Mutations Among Carriers of Thalassemia in Shadegan City, Southwest of Iran
Doosti Irani A, Cheraghi Z, Bitaraf S, Cheraghi P, Safiri S. Prevalence of Alpha and Beta-Thalassemia Mutations Among Carriers of Thalassemia in Shadegan City, Southwest of Iran. Zahedan J Res Med Sci. 2015;17(8):e1032. doi: https://doi.org/10.17795/zjrms1032
The Prevalence of HBsAg, Anti-HCV, and Anti-HBc in Patients With β-Thalassemia Referred to Blood Banking Department of Ghaem Hospital in Mashhad, Northeast of Iran
Abrishami F, Golshan A. The Prevalence of HBsAg, Anti-HCV, and Anti-HBc in Patients With β-Thalassemia Referred to Blood Banking Department of Ghaem Hospital in Mashhad, Northeast of Iran. Int J Infect. 2018;5(3):e81518. doi: https://doi.org/10.5812/iji.81518
Early Diagnosis of Cardiac Involvement in β-Thalassemia Major
Nooria NM. Early Diagnosis of Cardiac Involvement in β-Thalassemia Major. Multidiscip Cardio Annal. 2011;3(2):e8740. doi:
The prevalence and risk factors of hepatitis C virus infection among thalassemic patients of Qazvin (2005)
Bozorgi H, Ramezani H, Vahid T, Mstajeri A, Kargarfard H, et al. The prevalence and risk factors of hepatitis C virus infection among thalassemic patients of Qazvin (2005). J Inflamm Dis. 2024;11(4):e155361. doi:
- Scopus by DOI: 0
Last Update: 6 days ago
- Scopus by Title: 0
Last Update: 6 days ago
- Scopus by Title (Ref): 0
Last Update: 6 days ago
- CrossRef: 0
Last Update: 6 days ago
- OpenAlex: 1
Last Update: 6 hours ago
- OpenCitations: 0
Last Update: 4 days ago